Chinese authorities have approved 113 domestically developed innovative drugs for market entry since 2021, with the scale of the market now at 100 billion yuan (about 13.89 billion U.S. dollars), a conference in Shanghai revealed on Saturday, Azernews reports, citing Xinhua.
Categories